Table 2.
Dependent Variables | NT-proBNP IP (pg/mL) |
R2 | b<IP | p value at <IP |
b>IP | p value at >IP |
---|---|---|---|---|---|---|
BMI, kg/m2 | 95 | 0.007 | −0.01 (0.002) | <.0001 | −0.0003 (0.0003) | 0.4 |
Total Cholesterol, mg/dL | 50 | 0.03 | −0.21 (0.03) | <.0001 | −0.001 (0.002) | 0.6 |
LDL-C, mg/dL | 90 | 0.01 | −0.11 (0.02) | <.0001 | 0.0008 (0.002) | 0.7 |
HDL-C, mg/dL | 120 | 0.17 | 0.04 (0.005) | <.0001 | −0.00002 (0.0008) | 1.0 |
Triglycerides, mg/dL | 60 | 0.01 | −0.39 (0.07) | <.0001 | 0.0005 (0.005) | 0.9 |
Glucose, mg/dL | 65 | 0.05 | −0.14 (0.02) | <.0001 | 0.002 (0.002) | 0.4 |
HOMA-IR | 65 | 0.01 | −0.02 (0.005) | <.0001 | 0.0003 (0.0004) | 0.5 |
BMI = body mass index. IP = inflection point. The unadjusted b values are slopes for each dependent variable regressed on baseline NT-proBNP < and > the IP value. Each row represents a single linear spline model, that is, the regression equation is dependent variables = a + b<IP*(NT-proBNP − IP) + b>IP*(NT-proBNP − IP) * INT-proBNP >IP. Where a = intercept. The IP was chosen as the NT-proBNP value between 20 – 300 pg/mL with the highest R2.